Gary Gustafson

Especialista sênior de sucesso do cliente do CAS

Bio

PPI inhibitors show promise in cancer trials

Small molecule PPI inhibitors are on the brink of improving cancer treatments
|Artigo

Are covalent inhibitors the key to curing cancer?

CAS and Totus Medicines discuss how targeted covalent inhibitors are revolutionizing cancer treatments.
|Artigo